Evidence map›Paper›PMID 24797181›Full record

Trial reportBone marrow transplantation2014

A higher number of infused CD34(+) cells has a positive impact on the clinical outcome after related PBSC transplantation.

K Maie, S Fuji, K Tajima, M Tatsuno, S Yamagata, N Takahashi, R Ueda, H Hashimoto, K Takano, Y Inoue and 9 more

Abstract readClinical TrialLetter
PubMed Publisher
In one paragraph

Trial report in Bone marrow transplantation, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Impact of CD34Blood research · 2025
    Article
  2. Article
  3. A high CD34Bone marrow transplantation · 2020
    Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

K Maie1] Hematopoietic Stem Cell Transplantation Division, National Cancer Center Hospital, Tokyo, Japan [2] Department of Hematology, University of Tsukuba, Tsukuba, Japan.
S FujiHematopoietic Stem Cell Transplantation Division, National Cancer Center Hospital, Tokyo, Japan.
K TajimaHematopoietic Stem Cell Transplantation Division, National Cancer Center Hospital, Tokyo, Japan.
M TatsunoHematopoietic Stem Cell Transplantation Division, National Cancer Center Hospital, Tokyo, Japan.
S YamagataHematopoietic Stem Cell Transplantation Division, National Cancer Center Hospital, Tokyo, Japan.
N TakahashiHematopoietic Stem Cell Transplantation Division, National Cancer Center Hospital, Tokyo, Japan.
R UedaHematopoietic Stem Cell Transplantation Division, National Cancer Center Hospital, Tokyo, Japan.
H HashimotoHematopoietic Stem Cell Transplantation Division, National Cancer Center Hospital, Tokyo, Japan.
K TakanoHematopoietic Stem Cell Transplantation Division, National Cancer Center Hospital, Tokyo, Japan.
Y InoueHematopoietic Stem Cell Transplantation Division, National Cancer Center Hospital, Tokyo, Japan.
A ItoHematopoietic Stem Cell Transplantation Division, National Cancer Center Hospital, Tokyo, Japan.
Y HayashiHematopoietic Stem Cell Transplantation Division, National Cancer Center Hospital, Tokyo, Japan.
K OkinakaHematopoietic Stem Cell Transplantation Division, National Cancer Center Hospital, Tokyo, Japan.
S KurosawaHematopoietic Stem Cell Transplantation Division, National Cancer Center Hospital, Tokyo, Japan.
S-W KimHematopoietic Stem Cell Transplantation Division, National Cancer Center Hospital, Tokyo, Japan.
R TanosakiDepartment of Blood Transfusion and Cellular Therapy, National Cancer Center Hospital, Tokyo, Japan.
Y HeikeHematopoietic Stem Cell Transplantation Division, National Cancer Center Hospital, Tokyo, Japan.
T YamashitaHematopoietic Stem Cell Transplantation Division, National Cancer Center Hospital, Tokyo, Japan.
T FukudaHematopoietic Stem Cell Transplantation Division, National Cancer Center Hospital, Tokyo, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Antigens, CD34Peripheral Blood Stem Cell TransplantationTransplantation ConditioningAdultAgedAge FactorsAllograftsFemaleHematologic NeoplasmsHumansMaleMiddle AgedRetrospective StudiesAntigens, CD34

Identifiers

PMID24797181

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.